Neuberger Berman Group LLC decreased its position in Aetna Inc. (NYSE:AET) by 9.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,144,209 shares of the company’s stock after selling 117,577 shares during the period. Neuberger Berman Group LLC owned about 0.33% of Aetna worth $132,099,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. A.R.T. Advisors LLC acquired a new position in shares of Aetna during the first quarter valued at approximately $1,504,000. Squarepoint Ops LLC raised its position in shares of Aetna by 206.7% in the first quarter. Squarepoint Ops LLC now owns 21,570 shares of the company’s stock valued at $2,423,000 after buying an additional 14,538 shares during the period. Logan Capital Management Inc. raised its position in shares of Aetna by 2.6% in the first quarter. Logan Capital Management Inc. now owns 5,420 shares of the company’s stock valued at $609,000 after buying an additional 139 shares during the period. First Republic Investment Management Inc. raised its position in shares of Aetna by 244.5% in the first quarter. First Republic Investment Management Inc. now owns 59,852 shares of the company’s stock valued at $6,724,000 after buying an additional 42,480 shares during the period. Finally, BlueMountain Capital Management LLC raised its position in shares of Aetna by 430.7% in the first quarter. BlueMountain Capital Management LLC now owns 8,756 shares of the company’s stock valued at $984,000 after buying an additional 7,106 shares during the period. 90.76% of the stock is currently owned by institutional investors.
Shares of Aetna Inc. (NYSE:AET) traded up 0.19% during mid-day trading on Friday, hitting $129.57. The company had a trading volume of 1,281,217 shares. The stock has a market cap of $45.47 billion, a price-to-earnings ratio of 18.69 and a beta of 0.54. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $131.08. The stock’s 50-day moving average is $114.92 and its 200-day moving average is $116.41.
Aetna (NYSE:AET) last issued its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.02 by $0.05. Aetna had a return on equity of 16.25% and a net margin of 3.91%. The firm had revenue of $15.78 billion for the quarter, compared to analysts’ expectations of $15.71 billion. During the same quarter last year, the firm earned $1.90 earnings per share. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities analysts forecast that Aetna Inc. will post $8.02 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 28th. Investors of record on Thursday, October 13th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date was Tuesday, October 11th. Aetna’s payout ratio is currently 14.49%.
AET has been the topic of several research analyst reports. Evercore ISI initiated coverage on Aetna in a report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price objective on the stock. Credit Suisse Group AG reiterated a “hold” rating and issued a $120.00 price objective on shares of Aetna in a report on Tuesday, September 13th. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $128.00 price objective on the stock in a report on Tuesday, October 4th. Leerink Swann reiterated an “outperform” rating on shares of Aetna in a report on Wednesday, August 24th. Finally, FBR & Co reiterated a “hold” rating on shares of Aetna in a report on Wednesday, August 17th. Seven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $132.14.
In related news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.90% of the stock is owned by corporate insiders.